• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes.2型糖尿病患者血清Dickkopf-1与蛋白尿之间的关系。
World J Diabetes. 2021 Jan 15;12(1):47-55. doi: 10.4239/wjd.v12.i1.47.
2
Sex Difference in the Association Between Serum Versican and Albuminuria in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者血清核心蛋白聚糖与蛋白尿关联中的性别差异
Diabetes Metab Syndr Obes. 2023 Nov 11;16:3631-3639. doi: 10.2147/DMSO.S434287. eCollection 2023.
3
Endocan and albuminuria in type 2 diabetes mellitus.2型糖尿病中的内脂素与蛋白尿
Ren Fail. 2016 Nov;38(10):1647-1653. doi: 10.1080/0886022X.2016.1229966. Epub 2016 Oct 18.
4
Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.基于生物信息学分析的血清 25-羟维生素 D 水平与糖尿病肾病患者白蛋白尿进展的相关性及其潜在机制。
Front Endocrinol (Lausanne). 2022 May 12;13:880930. doi: 10.3389/fendo.2022.880930. eCollection 2022.
5
Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes.较高的血清阿朴脂蛋白水平与2型糖尿病患者的尿白蛋白排泄及肾功能相关。
Diabetes Metab Syndr Obes. 2020 Nov 13;13:4341-4351. doi: 10.2147/DMSO.S283413. eCollection 2020.
6
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial.恩格列净对 2 型糖尿病合并已确诊心血管疾病患者的尿白蛋白与肌酐比值的影响:来自 EMPA-REG OUTCOME 随机、安慰剂对照试验的探索性分析。
Lancet Diabetes Endocrinol. 2017 Aug;5(8):610-621. doi: 10.1016/S2213-8587(17)30182-1. Epub 2017 Jun 27.
7
[Urinary retinol binding protein and β-microglobulin were associated with urinary albumin to creatinine ratio and renal function in hospitalized diabetic patients].[尿视黄醇结合蛋白和β-微球蛋白与住院糖尿病患者的尿白蛋白肌酐比值及肾功能相关]
Zhonghua Nei Ke Za Zhi. 2021 May 1;60(5):438-445. doi: 10.3760/cma.j.cn112138-20200515-00483.
8
Association of Serum Tsukushi Levels with Urinary Albumin-Creatinine Ratio in Type 2 Diabetes Patients.2型糖尿病患者血清骨桥蛋白水平与尿白蛋白肌酐比值的相关性
Diabetes Metab Syndr Obes. 2024 Sep 4;17:3295-3303. doi: 10.2147/DMSO.S468228. eCollection 2024.
9
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.达格列净对伴有和不伴有 2 型糖尿病的慢性肾脏病患者尿白蛋白排泄的影响:来自 DAPA-CKD 试验的预设分析。
Lancet Diabetes Endocrinol. 2021 Nov;9(11):755-766. doi: 10.1016/S2213-8587(21)00243-6. Epub 2021 Oct 4.
10
[Change and significance of urinary smad3 in type 2 diabetic nephropathy].2型糖尿病肾病患者尿Smad3的变化及意义
Zhonghua Yi Xue Za Zhi. 2013 Apr 9;93(14):1067-71.

引用本文的文献

1
Knockout of KLF10 Ameliorated Diabetic Renal Fibrosis via Downregulation of DKK-1.敲除 KLF10 可通过下调 DKK-1 减轻糖尿病肾病纤维化。
Molecules. 2022 Apr 20;27(9):2644. doi: 10.3390/molecules27092644.
2
Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis.靶向Wnt/β-连环蛋白信号通路作为肾小管间质纤维化的潜在治疗策略
Front Pharmacol. 2021 Aug 16;12:719880. doi: 10.3389/fphar.2021.719880. eCollection 2021.

本文引用的文献

1
Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities.了解糖尿病肾病中的分子失调,以确定新的靶点和治疗机会。
Drug Discov Today. 2020 May;25(5):862-878. doi: 10.1016/j.drudis.2020.01.008. Epub 2020 Jan 22.
2
Diabetic kidney diseases revisited: A new perspective for a new era.重新审视糖尿病肾病:新时代的新视角。
Mol Metab. 2019 Dec;30:250-263. doi: 10.1016/j.molmet.2019.10.005. Epub 2019 Oct 17.
3
WNT Signaling in Disease.WNT 信号通路与疾病
Cells. 2019 Aug 3;8(8):826. doi: 10.3390/cells8080826.
4
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism.对糖尿病并发症机制的新认识:脂质及其代谢的作用。
Diabetologia. 2019 Sep;62(9):1539-1549. doi: 10.1007/s00125-019-4959-1. Epub 2019 Jul 25.
5
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies.糖尿病肾病:分子机制与新兴疗法的深入探讨。
Expert Opin Ther Targets. 2019 Jul;23(7):579-591. doi: 10.1080/14728222.2019.1624721. Epub 2019 Jun 3.
6
Evolving spectrum of diabetic nephropathy.糖尿病肾病的演变谱
World J Diabetes. 2019 May 15;10(5):269-279. doi: 10.4239/wjd.v10.i5.269.
7
Protective or deleterious role of Wnt/beta-catenin signaling in diabetic nephropathy: An unresolved issue.Wnt/β-catenin 信号在糖尿病肾病中的保护或损害作用:一个未解决的问题。
Pharmacol Res. 2019 Jun;144:151-157. doi: 10.1016/j.phrs.2019.03.022. Epub 2019 Mar 29.
8
Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.糖尿病肾病中的肾小球系膜细胞和足细胞损伤
Nephrology (Carlton). 2018 Oct;23 Suppl 4:32-37. doi: 10.1111/nep.13451.
9
Dickkopf-1: Current knowledge and related diseases.Dickkopf-1:当前知识与相关疾病。
Life Sci. 2018 Sep 15;209:249-254. doi: 10.1016/j.lfs.2018.08.019. Epub 2018 Aug 10.
10
β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.β-arrestin1/2 通过 Wnt/β-catenin 通路加重糖尿病肾病足细胞凋亡。
Med Sci Monit. 2018 Mar 24;24:1724-1732. doi: 10.12659/msm.905642.

2型糖尿病患者血清Dickkopf-1与蛋白尿之间的关系。

Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes.

作者信息

Hou Ning-Ning, Kan Cheng-Xia, Huang Na, Liu Yong-Ping, Mao En-Wen, Ma Yu-Ting, Han Fang, Sun Hong-Xi, Sun Xiao-Dong

机构信息

Department of Endocrinology, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.

Department of Pathology, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong Province, China.

出版信息

World J Diabetes. 2021 Jan 15;12(1):47-55. doi: 10.4239/wjd.v12.i1.47.

DOI:10.4239/wjd.v12.i1.47
PMID:33520107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7807253/
Abstract

BACKGROUND

Diabetic kidney disease is a microvascular complication of diabetes with complex pathogenesis. Wingless signaling-mediated renal fibrosis is associated with diabetic kidney disease. Dickkopf-1, a negative regulator of Wingless, has been proven to participate in renal fibrosis, glucose metabolism, and inflammation. However, whether serum Dickkopf-1 levels are associated with diabetic kidney disease remains unclear.

AIM

To assess the relationship between serum Dickkopf-1 levels and albuminuria in individuals with type 2 diabetes.

METHODS

Seventy-three type 2 diabetes patients and 24 healthy individuals were enrolled in this case-control study. Diabetic individuals were separated into normal albuminuria, microalbuminuria, and macroalbuminuria groups based on their urinary albumin/creatinine ratios (UACRs). Clinical characteristics and metabolic indices were recorded. Serum Dickkopf-1 levels were determined by enzyme-linked immunosorbent assay.

RESULTS

No significant difference in serum Dickkopf-1 levels was found between healthy individuals and the normal albuminuria group. However, the levels in the microalbuminuria group were significantly lower than those in the normal albuminuria group ( = 0.017), and those in the macroalbuminuria group were the lowest. Bivariate analysis revealed that serum Dickkopf-1 levels were positively correlated with hemoglobin A1c level ( = 0.368, < 0.01) and estimated glomerular filtration rate ( = 0.339, < 0.01), but negatively correlated with diabetes duration ( = -0.231, = 0.050), systolic blood pressure ( = -0.369, = 0.001), serum creatinine level ( = -0.325, < 0.01), and UACR ( = -0.459, < 0.01). Multiple and logistic regression showed that serum Dickkopf-1 levels were independently associated with UACR (odds ratio = 0.627, = 0.021).

CONCLUSION

Serum Dickkopf-1 levels are negatively associated with UACR. Lower serum Dickkopf-1 levels could be a critical risk factor for albuminuria in diabetes.

摘要

背景

糖尿病肾病是糖尿病的一种微血管并发症,其发病机制复杂。无翅信号介导的肾纤维化与糖尿病肾病相关。Dickkopf-1是无翅信号的负调节因子,已被证明参与肾纤维化、糖代谢和炎症反应。然而,血清Dickkopf-1水平是否与糖尿病肾病相关仍不清楚。

目的

评估2型糖尿病患者血清Dickkopf-1水平与蛋白尿之间的关系。

方法

本病例对照研究纳入了73例2型糖尿病患者和24例健康个体。根据尿白蛋白/肌酐比值(UACR)将糖尿病个体分为正常蛋白尿组、微量白蛋白尿组和大量白蛋白尿组。记录临床特征和代谢指标。采用酶联免疫吸附测定法测定血清Dickkopf-1水平。

结果

健康个体与正常蛋白尿组血清Dickkopf-1水平无显著差异。然而,微量白蛋白尿组的水平显著低于正常蛋白尿组(P = 0.017),大量白蛋白尿组的水平最低。双变量分析显示,血清Dickkopf-1水平与糖化血红蛋白水平呈正相关(r = 0.368,P < 0.01)和估计肾小球滤过率呈正相关(r = 0.339,P < 0.01),但与糖尿病病程呈负相关(r = -0.231,P = 0.050)、收缩压呈负相关(r = -0.369,P = 0.001)、血清肌酐水平呈负相关(r = -0.325,P < 0.01)和UACR呈负相关(r = -0.459,P < 0.01)。多元和逻辑回归显示,血清Dickkopf-1水平与UACR独立相关(比值比 = 0.627,P = 0.021)。

结论

血清Dickkopf-1水平与UACR呈负相关。较低的血清Dickkopf-1水平可能是糖尿病患者蛋白尿的关键危险因素。